Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Haloperidol). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Haloperidol এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Tablet-Initial dose for adults- Moderate symptomatology: 0.5 mg to 3.0 mg 2 to 3 times daily Severe symptomatology: 3.0 mg to 5.0 mg 2 to 3 times daily Elderly patients: 0.5 mg to 4.5 mg 2 to 3 times daily Chronic or Resistant patients: 3.0 mg to 6.0 mg 2 to 3 times daily Patients who remain severely disturbed or inadequately controlled may require dose adjustment. Daily dose upto 100 mg may be necessary in some cases to achieve optimal response. Children: A suggested dose for the management of behaviour disorders in disturbed and schizophrenic children is 50 microgram per kg body weight.Injection (intramuscular or intravenous)-Schizophrenia and other psychosis, mania: Initially 2-10 mg, then every 4-8 hours according to response to total maximum 18 mg daily Severely disturbed patients may require an initial dose of up to 18 mg Elderly (or debilitated) initially half adult dose For children not recommended.
পার্শ্বপ্রতিক্রিয়া
Halop is a safe neuroleptic. The most commonly encountered side effects are headache, vertigo and insomnia. Drowsiness, lethargy, stupor, confusion, restlessness, agitation, anxiety, euphoria and a worsening of psychotic symptoms, including hallucinations, may also occur. Dry mouth, blurred vision, urinary retention, heartburn, nausea, vomiting, loss of appetite, diarrhoea and excessive salivation have also been reported.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Haloperidol may lower the seizure threshold and has been reported to trigger seizures in people with epilepsy whose condition was previously well controlled. When starting Haloperidol in these patients, adequate anticonvulsant treatment should be continued alongside it. As with other antipsychotic medicines, Haloperidol should be used with care in patients with severe liver or kidney impairment, and in those with a known allergy or history of allergy to other neuroleptic drugs. Care is also needed in patients with pheochromocytoma, and in those with conditions that make seizures more likely, such as alcohol withdrawal and brain injury. Because Haloperidol may strengthen the effects of strong painkillers or sleeping medicines, caution is advised when prescribing it to patients who take such drugs regularly.
নিষেধাজ্ঞা
Haloperidol should not be used in patients who are in a coma or who have CNS depression caused by alcohol or other depressant drugs. It is also contraindicated in severe depressive states, in those with a history of spastic diseases, in patients with lesions of the basal ganglia, and in Parkinson's syndrome, except where the problem is dyskinesia brought on by levodopa treatment. People who are sensitive to haloperidol should not take it, nor should senile patients who already have Parkinson-like symptoms.